Incident genital HPV infections and potential impact of HPV vaccines in adult women living with HIV/AIDS

References

• Brown DR, Shew ML, Qadadri B, Neptune N, Vargas M, Tu W, Juliar BE, Breen T, Fortenberry JD. A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. J Infect Dis. 2005;191(2):182–192. doi:10.1086/426867.
   PubMed Web of Science ®Google Scholar
• Harper DM, DeMars LR. HPV vaccines – A review of the first decade. Gynecol Oncol. 2017;146(1):196–204. doi:10.1016/j.ygyno.2017.04.004.
   PubMed Web of Science ®Google Scholar
• Lewis RM, Markowitz LE, Gargano JV, Steinau M, Unger ER. Prevalence of genital human papillomavirus among sexually experienced males and females aged 14-59 years, United States, 2013-2014. J Infect Dis. 2018;204(4):566–573. doi:10.1093/infdis/jix655.
   Web of Science ®Google Scholar
• Tartaglia E, Falasca K, Vecchiet J, Sabusco GP, Picciano G, Di Marco R, Ucciferri C. Prevalence of HPV infection among HIV-positive and HIV-negative women in Central/Eastern Italy: strategies of prevention. Oncol Lett. 2017;14(6):7629–7635. doi:10.3892/ol.2017.7140.
   PubMed Web of Science ®Google Scholar
• Ellerbrock TV, Chiasson MA, Bush TJ, Sun XW, Sawo D, Brudney K, Wright TC jr. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA. 2000;283(8):1031–1037. doi:10.1001/jama.283.8.1031.
   PubMed Web of Science ®Google Scholar
• Gilles C, Manigart Y, Konopnicki D, Barlow P, Rozenberg S. Management and outcome of cervical intraepithelial neoplasia lesions: a study of matched cases according to HIV status. Gynecol Oncol. 2005;96(1):112–118. doi:10.1016/j.ygyno.2004.10.003.
   PubMed Web of Science ®Google Scholar
• Clifford GM, Tully S, Franceschi S. Carcinogenicity of Human Papillomavirus (HPV) types in HIV-positive women: a meta-analysis from HPV Infection to Cervical Cancer. Clin Infect Dis. 2017;64(9):1228–1235. doi:10.1093/cid/cix135.
   PubMed Web of Science ®Google Scholar
• Viscidi RP, Schiffman M, Hildesheim A, Herrero R, Castle PE, Bratti MC, Rodriguez AC, Sherman ME, Wang S, Clayman B, et al. Seroreactivity to Human Papillomavirus (HPV) types 16, 18, or 31 and risk of subsequent HPV infection: results from a population-based study in costa rica. Cancer Epidemiol Biomarkers Prev. 2004;13(2): 324–327.doi:10.1158/1055-9965.
   PubMed Web of Science ®Google Scholar
• Orlando G, Tanzi E, Chatenoud L, Gramegna M, Rizzardini G; VALHIDATE Study Group. Rationale and design of a multicenter prospective cohort study for the eVALuation and monitoring of HPV infections and relATEd cervical diseases in high-risk women (VALHIDATE study). BMC Cancer. 2012;12:204. doi:10.1186/1471-2407-12-204.
   PubMed Web of Science ®Google Scholar
• IARC. Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum. 2011;100B:261–319.
   Google Scholar
• Konopnicki D, Manigart Y, Gilles C, Barlow P, De Marchin J, Feoli F, Delforge M, Clumeck N, De Wit S. High-risk human papillomavirus genotypes distribution in a cohort of HIV-positive women living in Europe: epidemiological implication for vaccination against human papillomavirus. Aids. 2016;30(3):425–433. doi:10.1097/QAD.0000000000000929.
   PubMed Web of Science ®Google Scholar
• Bruni L, Diaz M, Castellsagué X, Ferrer E, Bosch FX, de Sanjosé S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 2010;202(12):1789–1799. doi:10.1086/657321.
   PubMed Web of Science ®Google Scholar
• Rowhani-Rahbar A, Hawes SE, Sow PS, Toure P, Feng Q, Dem A, Dembele B, Critchlow CW, N’Doye I, Kiviat NB. The impact of HIV status and type on the clearance of human papillomavirus infection among Senegalese women. J Infect Dis. 2007;196(6):887–894. doi:10.1086/520883.
   PubMed Web of Science ®Google Scholar
• Massad LS, Xie X, D’Souza G, Darragh TM, Minkoff H, Wright R, Colie C, Sanchez-Keeland L, Strickler HD. Incidence of cervical precancers among HIV-seropositive women. Am J Obstet Gynecol. 2015;212(5):606.e1–8. doi:10.1016/j.ajog.2014.12.003.
   PubMed Web of Science ®Google Scholar
• Clifford GM, Franceschi S, Keiser O, Schoni-Affolter F, Lise M, Dehler S, Levi F, Mousavi M, Bouchardy C, Wolfensberger A, et al. Immunodeficiency and the risk of cervical intraepithelial neoplasia 2/3 and cervical cancer: a nested case-control study in the Swiss HIV cohort study. Int J Cancer. 2016;138(7): 1732–1740.doi:10.1002/ijc.29913.
   PubMed Web of Science ®Google Scholar
• Abraham AG, Strickler HD, D’Souza G. Invasive cervical cancer risk among HIVinfected women is a function of CD4 count and screening. J Acquir Immune Defic Syndr. 2013;63(5):e163. doi:10.1097/QAI.0b013e31829cb7c3.
   PubMed Web of Science ®Google Scholar
• Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007;370(9581):59–67. doi:10.1016/S0140-6736(07)61050-2.
   PubMed Web of Science ®Google Scholar
• Munoz N, Mendez F, Posso H, Molano M, van Den Brule AJ, Ronderos M, Meijer C, Munoz A; Instituto Nacional de Cancerologia HPV Study Group. Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results. J Infect Dis. 2004;190(12):2077–2087. doi:10.1086/425907.
   PubMed Web of Science ®Google Scholar
• Trottier H, Ferreira S, Thomann P, Costa MC, Sobrinho JS, Prado JC, Rohan TE, Villa LL, Franco EL. Human papillomavirus infection and reinfection in adult women: the role of sexual activity and natural immunity. Cancer Res. 2010;70(21):8569–8577. doi:10.1158/0008-5472.
   PubMed Web of Science ®Google Scholar
• Maglennon GA, McIntosh PB, Doorbar J. Immunosuppression facilitates the reactivation of latent papillomavirus infections. J Virol. 2014;88(1):710–716. doi:10.1128/JVI.02589-13.
   PubMed Web of Science ®Google Scholar
• Massad LS, Xie X, Burk RD, D’Souza G, Darragh TM, Minkoff H, Colie C, Burian P, Palefsky J, Atrio J, et al. Association of cervical precancer with human papillomavirus types other than 16 among HIV co-infected women. Am J Obstet Gynecol. 2016;214:354. e1-6. doi:10.1016/j.ajog.2015.09.086
   PubMed Web of Science ®Google Scholar
• Keller MJ, Burk RD, Massad LS, Eltoum IE, Hessol NA, Castle PE, Anastos K, Xie X, Minkoff K, Xue X, et al. Cervical precancer risk in HIV-infected women who test positive for oncogenic human papillomavirus despite a normal Pap test. Clin Infect Dis. 2015;61(10): 1573–1581.doi:10.1093/cid/civ569.
   PubMed Web of Science ®Google Scholar
• Joura EA, Giuliano AR, Iversen OE, Bouchard C, Mao C, Mehlsen J, Moreira ED, Ngan Y, Petersen LK, Lazcano-Ponce E, et al. A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med. 2015;372(8): 711–723.doi:10.1056/NEJMoa1405044.
   PubMed Web of Science ®Google Scholar
• Chesson HW, Markowitz LE, Hariri S, Ekwueme DU, Saraiya M. The impact and cost-effectiveness of nonavalent HPV vaccination in the United States: estimates from a simplified transmission model. Hum Vaccin Immunother. 2016;12(6):1363–1372. doi:10.1080/21645515.2016.1140288.
   PubMed Web of Science ®Google Scholar
• Durham DP, Ndeffo-Mbah ML, Skrip LA, Jones FK, Bauch CT, Galvani AP. National- and state-level impact and cost-effectiveness of nonavalent HPV vaccination in the United States. Proc Natl Acad Sci U S A. 2016;113(18):5107–5112. doi:10.1073/pnas.1515528113.
   PubMed Web of Science ®Google Scholar
• Solomon D, Davey D, Kurman R, Moriarty A, O’Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T jr, et al. The 2001 bethesda system: terminology for reporting results of cervical cytology. JAMA. 2002;287(16): 2114–2119.doi:10.1001/jama.287.16.2114.
   PubMed Web of Science ®Google Scholar
• Gestione della paziente con Pap test anormale. Linee guida Edizione 2006. www.colposcopiaitaliana.it/pdf07/linee-guida-2006.pdf
   Google Scholar
• Tanzi E, Bianchi S, Fasolo MM, Frati ER, Mazza F, Martinelli M, Colzani D, Beretta R, Zappa A, Orlando G. High performance of a new PCR-based urine assay for HPV-DNA detection and genotyping. J Med Virol. 2013;85(1):91–98. doi:10.1002/jmv.23434.
   PubMed Web of Science ®Google Scholar